Commercialization: Page 38
-
PharmaVoice Team/PharmaVoice
Innovation Centers of Excellence
Research parks began to grow in the 1950s as part of a wave of collaborations with universities, private developers, and governments that created labs and research space for industry and academia. Now, a new wave of innovation districts are popping up in major cities: innovation hubs within city ...
By PharmaVoice Team • April 1, 2016 -
PharmaVoice Team/PharmaVoice
Innovative Companies
Companies from Apple to Alphabet to Johnson & Johnson and IBM are driving innovative approaches to improving healthcare and patient care. Apple, which has clearly been a worldwide leader in innovation, is now also looking to “make a significant contribution to culture," says Jay Gronlund, pre...
By PharmaVoice Team • April 1, 2016 -
PharmaVoice Team/PharmaVoice
Sustaining Innovation
Business has entered a challenging new world full of opportunities for strategic innovation, and sustainability will be a major driver of these opportunities into the future. The new framework, which already dominates in a handful of the world’s leading companies, is solution-oriented strategic i...
By PharmaVoice Team • April 1, 2016 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Digitizing the Industry In this month’s Forum, we explore the opportunities, challenges, and processes involved in the industry’s transformation into the digital age. For most of us, digital technologies have become part of our every day life, yet many pharmaceutical companies are still navigati...
By Taren Grom • March 1, 2016 -
PharmaVoice Team/PharmaVoice
UpFront
Industry at Large Endo Launches Scholarship Program New initiative honoring the Qualitest name is designed to reward students in the Huntsville, Ala., region pursuing higher education. Endo International has funded a new scholarship program designed to make higher education more accessible for th...
By PharmaVoice Team • March 1, 2016 -
PharmaVoice Team/PharmaVoice
mHealth
Pressure Sensitive Gloves Designed To Detect Tumors Trending now: From gloves with built-in sensors to dissolving brain implants, technology is changing how health information is collected. Healthcare practitioners may one day be able to physically screen for breast cancer using pressure-sensitiv...
By PharmaVoice Team • March 1, 2016 -
PharmaVoice Team/PharmaVoice
The Calendar
Coming Attractions The 5th Annual Outsourcing in Clinical Trials Southeast Conference will take place March 15 and 16 in Cary, N.C. Attendees will have the chance to discuss, deliberate, and debate the latest operational and outsourcing challenges in conducting clinical trials. This two-day, cont...
By PharmaVoice Team • March 1, 2016 -
PharmaVoice Team/PharmaVoice
Digital-Enabled Business Models
The industry is in the beginning stages of a great transformation created by digital influences within healthcare. Although many companies are only starting to consider the implications of the digital environment on their business models, several reports state that by 2020, digital will be embedd...
By Robin Robinson • March 1, 2016 -
PharmaVoice Team/PharmaVoice
Creating Great Creative
The Creative Key Elements One marketing expert has stated that in addition to hard work, there are usually four key elements in a great ad: a disruptive and relevant visual, strong brand identification, a brilliant headline, and “something else." Industry creative experts discuss what they believ...
By Taren Grom • March 1, 2016 -
PharmaVoice Team/PharmaVoice
Preparing for an Outcomes-based Sales Model
According to a recent report by Accenture, three factors — reimbursement models, changing buyer profiles, and digital capabilities — are changing the pharmaceutical and healthcare industries and directly impacting the traditional pharmaceutical sales rep model. However, these factors also represe...
By Robin Robinson • March 1, 2016 -
PharmaVoice Team/PharmaVoice
Gaining Value from the EHR Analytics
In January of this year, the Centers for Medicare & Medicaid Services (CMS) announced its plan to transition from the staged meaningful use program to a new program that would put patients and their outcomes at the center of how it pays for care and supports physicians. The intent is to conti...
By Robin Robinson • March 1, 2016 -
PharmaVoice Team/PharmaVoice
Caring for Those with Brain Disorders
Many of us will be caregivers at some point in our lives. Age, debilitating disease, and chronic health conditions mean many of us will take on the role of caring for relatives. An estimated 43.5 million adults in the United States have provided unpaid care to an adult or a child in the prior 12 ...
By Denise Myshko • March 1, 2016 -
PharmaVoice Team/PharmaVoice
Despite Turbulence, Russia's Pharma Market Holds Promise
The world’s largest nation, Russia remains an attractive market for most industries. Nevertheless, the country has struggled through a rough economic period, rocked by a drop in the value of the currency and turbulence in the oil market. Geopolitical pressures have raised challenges, including sa...
By Kim Ribbink • March 1, 2016 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Market Research
MarketResearch.com asked a variety of executives and thought leaders to share their predictions on the trends market researchers should expect in 2016 (see box: 15 Predicted Market Research Trends for 2016). These respondents cited a range of influential factors, including the role of mobile devi...
By Taren Grom • March 1, 2016 -
PharmaVoice Team/PharmaVoice
For Optimized Brand Strategies, Look to Market Research
Mark Twain is one of our favorite authors — and not just because of classics like The Adventures of Tom Sawyer and its sequel The Adventures of Huckleberry Finn, but also for an array of funny quotes, such as “Get your facts first, and then you can distort them as much as you please." That partic...
By Lori Gittleman • March 1, 2016 -
PharmaVoice Team/PharmaVoice
UpFront
Industry at Large Astellas Partners with Aspiritech to Advance Opportunities for Adults with Autism By harnessing the strengths of adults with high-functioning autism — attention to detail, precision, an affinity for repetitive tasks, and outstanding technology skills — Aspiritech is providing so...
By PharmaVoice Team • Feb. 1, 2016 -
PharmaVoice Team/PharmaVoice
Innovator's Corner
Researching Gene Therapies for Rare Diseases Karen Aiach, Founder and CEO of Lysogene, talks about the company’s mission to become experts in gene vector delivery to the brain. Diseases of the central nervous system are a challenge to treat because the blood brain barrier prevents large molecules...
By Karen Aiach • Feb. 1, 2016 -
PharmaVoice Team/PharmaVoice
mHealth
Novartis and Qualcomm’s Inhaler Device Helps Manage COPD Trendwatch: Apps and devices create better patient connectivity. Novartis and Qualcomm have collaborated to create the Breezhaler inhaler device to treat COPD. Under this partnership, Qualcomm Life will provide the technology solution for t...
By PharmaVoice Team • Feb. 1, 2016 -
PharmaVoice Team/PharmaVoice
What's New
Baxalta Opens Global Innovation Center Trending now: Baxalta joins growing list of Cambridge, Mass.-based innovators Baxalta, a global biopharmaceutical leader dedicated to delivering transformative therapies to patients with orphan diseases and underserved conditions, has opened its Global Inno...
By PharmaVoice Team • Feb. 1, 2016 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
Veeva Systems and UL EduNeering Partner to Deliver Integrated Learning Solution Trending Now: The partnership marries industry cloud solutions to improve quality and compliance across the value chain. UL EduNeering is delivering a connector integrating Veeva Vault QualityDocs, a cloud-based life...
By PharmaVoice Team • Feb. 1, 2016 -
PharmaVoice Team/PharmaVoice
The Calendar
Coming Attractions The Pennsylvania BIO 2016 Annual Dinner and Awards Celebration is the premier event of the season for the life-sciences industry in Pennsylvania. On March 10th, more than 1,000 attendees will convene for this can’t-miss event Thursday, March 10, 2016, at the PA Convention Cente...
By PharmaVoice Team • Feb. 1, 2016 -
PharmaVoice Team/PharmaVoice
Global Launches
Most of today’s new therapy launches are global, but the strategy behind those launches has changed significantly, due to the advent of more specialty drugs targeting smaller populations, and the impact of the shift in decision making from physician to payer. The industry can no longer rely on ph...
By Robin Robinson • Feb. 1, 2016 -
PharmaVoice Team/PharmaVoice
Advertising to Segments of the Customer Base
For many marketers today, audience segmentation is becoming a key strategic activity when conducting audience analysis. At the most basic level, audience segmentation is the process of dividing a large group of people into homogeneous subgroups — or segments — based upon those who have similar ne...
By Taren Grom • Feb. 1, 2016 -
PharmaVoice Team/PharmaVoice
The Coming Antibiotic Crisis
For the last 70 years, antibiotics have greatly reduced illness and death from infectious diseases. But these drugs have been used so widely and for so long that the infectious organisms the antibiotics are designed to kill have adapted to them, making the drugs less effective. In the past 25 yea...
By Denise Myshko • Feb. 1, 2016 -
PharmaVoice Team/PharmaVoice
Patients and Patient Organizations Power Rare Disease Therapies
For most of the pharmaceutical industry, the focus on patient centricity is a relatively new phenomenon, and the industry continues to shift its focus to include patients as stakeholders when planning its marketing strategies, clinical trials, and R&D strategies. However, for the rare disease...
By Robin Robinson • Feb. 1, 2016
Previous
